Murphy Middleton Hinkle & Parker’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $334K | Hold |
1,592
| – | – | 0.19% | 106 |
|
|
2025
Q1 | $334K | Hold |
1,592
| – | – | 0.19% | 106 |
|
|
2024
Q4 | $283K | Hold |
1,592
| – | – | 0.16% | 114 |
|
|
2024
Q3 | $314K | Hold |
1,592
| – | – | 0.17% | 114 |
|
|
2024
Q2 | $273K | Hold |
1,592
| – | – | 0.16% | 117 |
|
|
2024
Q1 | $290K | Hold |
1,592
| – | – | 0.17% | 117 |
|
|
2023
Q4 | $247K | Hold |
1,592
| – | – | 0.15% | 122 |
|
|
2023
Q3 | $237K | Hold |
1,592
| – | – | 0.15% | 127 |
|
|
2023
Q2 | $214K | Hold |
1,592
| – | – | 0.13% | 130 |
|
|
2023
Q1 | $254K | Sell |
1,592
-81
| -5% | -$12.9K | 0.16% | 122 |
|
|
2022
Q4 | $270K | Hold |
1,673
| – | – | 0.17% | 119 |
|
|
2022
Q3 | $224K | Buy |
1,673
+1
| +0.1% | +$134 | 0.16% | 118 |
|
|
2022
Q2 | $256K | Buy |
1,672
+1
| +0.1% | +$153 | 0.17% | 118 |
|
|
2022
Q1 | $271K | Buy |
1,671
+1
| +0.1% | +$162 | 0.15% | 125 |
|
|
2021
Q4 | $226K | Buy |
+1,670
| New | +$226K | 0.12% | 137 |
|